Skip to main content
PAS 2025 Meeting Main banner
Final Program


Schedule at a Glance
Icon Legend
Presentation Icons
Ticketed Event
Ticketed Event
Norman J. Siegel New Member Outstanding Science Award
Norman J. Siegel New Member Outstanding Science Award
John Howland Award
John Howland Award
Mary Ellen Avery Award
Mary Ellen Avery Award
SPR Thomas A. Hazinski Distinguished Service Award
SPR Thomas A. Hazinski Distinguished Service Award
SPR Douglas K. Richardson Award for Perinatal and Pediatric Healthcare Research
SPR Douglas K. Richardson Award for Perinatal and Pediatric Healthcare Research
PROSPER Diversity Award
PROSPER Diversity Award
ASPN Founders’ Award
ASPN Founders’ Award
David G. Nichols Health Equity Award
David G. Nichols Health Equity Award
ASPN Mid-Career Award
ASPN Mid-Career Award
Awarded Part 4 Maintenance of Certification (MOC) Credit
Awarded Part 4 Maintenance of Certification (MOC) Credit
Poster Icons
Awarded Part 4 Maintenance of Certification (MOC) Credit
Awarded Part 4 Maintenance of Certification (MOC) Credit
ViewAttendees 25

Emergency Medicine

Endocrinology

General Pediatrics

Hospital Medicine

Nephrology

Obesity

Pediatric Nutrition

Pharmacology and Therapeutics

Trainee

Diabetic kidney disease (DKD): Not just an adult problem!

The Role of SGLT2 Inhibitors and GLP-1R Agonists in Treatment and Prevention of DKD: the Adrian Spitzer Lectureship

Saturday, April 26, 2025
11:00am – 11:30am HST
Location:  Convention Center: 316 A

    Speaker(s)

  • Petter Bjornstad, MD

    Executive Director
    University of Washington School of Medicine, and Seattle Children's Hospital, United States

Disclosure(s):
Petter Bjornstad, MD: AstraZeneca (Ongoing) (Products/Services: Advisory Committee, Consultant, Research Support including clinical trials & the principal or named investigator); Boehringer-Ingelheim (Ongoing) (Products/Services: Advisory Committee, Consultant); Horizon / Amgen (Ongoing) (Products/Services: Consultant); Lilly (Ongoing) (Products/Services: Advisory Committee, Consultant); Merck (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Novo Nordisk (Ongoing) (Products/Services: Advisory Committee, Consultant, Research Support including clinical trials & the principal or named investigator)